Fractyl Health, Inc. GUTS
Set alert
0.97 USD -0.01 -0.69%
As of Nov 2, 10:25 AM ET
0.9401 Day range 0.9983
0.821 52-week range 29.34
- YTD
- -96.33%
- 1 year
- -93.43%
- Open
- 0.9983
- Prev close
- 0.9765
- Mkt cap
- 12.86M
- Vol
- 48.79K
- Avg vol
- 464.37K
- EPS
- -10.56
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.9401
- High
- 0.9983
- Forward P/E
- -0.77
- Beta
- 0.00
- Short ratio
- 5.48
- Inst. own
- 86.04%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 14, 2024
- 50-d avg
- 2.37
- 200-d avg
- 4.29
- 1y target
- 15.50
MAX chart
Events in this range
- Feb 27, 2024Rating: Morgan Stanley · — → Overweight
- Feb 28, 2024Rating: Evercore ISI Group · — → Outperform
- May 13, 2024Earnings: —; estimate -0.3; surprise —%
- May 13, 2024Earnings: -0.75; estimate -0.3; surprise -150%
- Aug 14, 2024Earnings: —; estimate -0.46; surprise —%
- Aug 14, 2024Earnings: -0.36; estimate -0.46; surprise 21.74%
- Nov 12, 2024Earnings: -0.48; estimate -0.5; surprise 4%
- Oct 5, 2026Split: 1 for 12
Signals (46)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Oct 12, 2026 | 3 weeks ago |
| MACD: Sell Signal | Sep 21, 2026 | 1 month ago |
| SMA: Bearish | Sep 7, 2026 | 1 month ago |
| SMA: Bearish | Aug 24, 2026 | 2 months ago |
| SMA: Bullish | Aug 17, 2026 | 2 months ago |
| SMA: Bullish | Aug 17, 2026 | 2 months ago |
| SMA: Bearish | Jul 20, 2026 | 3 months ago |
| SMA: Bullish | Jul 13, 2026 | 3 months ago |
| SMA: Bearish | Jun 22, 2026 | 4 months ago |
| SMA: Bullish | Jun 8, 2026 | 4 months ago |
| SMA: Bearish | Jun 1, 2026 | 5 months ago |
| MACD: Buy Signal | Apr 27, 2026 | 6 months ago |
| SMA: Bullish | Mar 30, 2026 | 7 months ago |
| SMA: Bearish | Jan 26, 2026 | 9 months ago |
| SMA: Bearish | Jan 26, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 26, 2026 | 9 months ago |
| SMA: Bullish | Jan 19, 2026 | 9 months ago |
| SMA: Bearish | Jan 12, 2026 | 9 months ago |
| SMA: Bullish | Nov 24, 2025 | 11 months ago |
| SMA: Bullish | Nov 10, 2025 | 11 months ago |
| SMA: Bearish | Nov 3, 2025 | 12 months ago |
| SMA: Bearish | Oct 6, 2025 | 1 year ago |
| SMA: Bullish | Sep 29, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 29, 2025 | 1 year ago |
| SMA: Bullish | Sep 22, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 11, 2025 | 1 year ago |
| SMA: Bearish | Aug 4, 2025 | 1 year ago |
| SMA: Bearish | Jul 28, 2025 | 1 year ago |
| SMA: Bullish | Jul 21, 2025 | 1 year ago |
| SMA: Bullish | Jul 14, 2025 | 1 year ago |
| SMA: Bearish | Jun 23, 2025 | 1 year ago |
| SMA: Bearish | Jun 23, 2025 | 1 year ago |
| SMA: Bullish | May 19, 2025 | 1 year ago |
| SMA: Bullish | Apr 28, 2025 | 1 year ago |
| SMA: Bearish | Jan 27, 2025 | 1 year ago |
| SMA: Bullish | Jan 20, 2025 | 1 year ago |
| SMA: Bearish | Dec 2, 2024 | 1 year ago |
| SMA: Bullish | Nov 25, 2024 | 1 year ago |
| SMA: Bearish | Nov 4, 2024 | 1 year ago |
| SMA: Bullish | Oct 28, 2024 | 2 years ago |
| RSI: Oversold | Sep 30, 2024 | 2 years ago |
| SMA: Bearish | Sep 2, 2024 | 2 years ago |
| SMA: Bullish | Aug 26, 2024 | 2 years ago |
| RSI: Oversold | Jun 3, 2024 | 2 years ago |
| SMA: Bearish | May 27, 2024 | 2 years ago |
| SMA: Bullish | May 13, 2024 | 2 years ago |
Financial health
Altman Z-Score
-13.44 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B-2 / 5 overall
- DCF 5
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -2.4×
FY 2019 5y median -6.5× FY 2025
P/S 0.0×
FY 2019 5y median 0.0× FY 2025
P/B 35.7×
FY 2019 5y median -1.9× FY 2025
P/FCF -3.7×
FY 2019 5y median -13.2× FY 2025
EV/EBITDA -2.3×
FY 2019 5y median -12.4× FY 2025
EV/Sales 0.0×
FY 2019 5y median 0.0× FY 2025
FCF Yield -26.9%
FY 2019 5y median -7.6% FY 2025
Profitability
Gross Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2019 5y median 0.0% FY 2025
ROE -1490.3%
FY 2019 5y median 18.4% FY 2025
ROIC -89.5%
FY 2019 5y median -89.5% FY 2025
ROA -116.1%
FY 2019 5y median -76.2% FY 2025
Growth (YoY)
Revenue -100.0%
FY 2019 FY 2025
Operating Income -3.5%
FY 2019 FY 2025
EPS (diluted) 43.2%
FY 2019 FY 2025
Free Cash Flow -35.1%
FY 2019 FY 2025
Financial Health
Current Ratio 4.8×
FY 2019 5y median 4.1× FY 2025
Quick Ratio 4.8×
FY 2019 5y median 4.1× FY 2025
Debt / Equity 6.5×
FY 2019 5y median -1.1× FY 2025
Net Debt / EBITDA 0.1×
FY 2019 5y median -4.4× FY 2025
Interest Coverage 0.0×
FY 2019 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31